Numantec / News
News
With a focus on innovation and the strengthening of a sector that is constantly growing and evolving, NUMANTEC was established—a new biomedical group composed of various entities specialized in healthcare assistance solutions.
Maintenance Kits for Vascular Access: Why Post-Insertion Management Affects Clinical Outcomes
Within the vascular access pathway, the post-insertion phase is just as important as device selection and insertion technique. Many complications...
In critically ill patients, monitoring intra-abdominal pressure (IAP) is a key parameter in preventing serious complications such as intra-abdominal hypertension...
Despite technological advances and the ongoing evolution of clinical practice, vascular access failure continues to represent a significant challenge within...
In recent years, international vascular access guidelines have progressively shifted their focus from individual devices to a broader, more structured...
In vascular access management, choosing the most appropriate device directly impacts the ability to reduce complications, improve continuity of therapy,...
Numantec and Cair LGL Sign Exclusive U.S. and Canada Distribution Agreement for NeutraClear™ Needle-Free Connectors and Extension Sets
Salt Lake City, April 20, 2026 — Numantec Group today announced that, through its U.S.-based subsidiary Health Line International Corp....
From 19 to 22 May 2026, the Numantec Group will take part in Hospitalar 2026, one of the most important...
Numantec at the GAVePed Congress: Integrated Solutions for Pediatric and Neonatal Vascular Access
Numantec will take part in the 8th GAVePed Congress, one of the leading events in Italy dedicated to vascular access...
Vascular access management does not end at the time of insertion; it requires continuous attention throughout daily use. Disinfection of...
